A definitive study of the type-2 mediators and signalling components that generate protective immunity to a gut nematode
FOXO4-DRI acts as a decoy that competes with FOXO4 for p53
Jul., Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD), Diabetes Care , vol
Over 90% Glutathione Purity
Anti-Inflammatory Pathways: GHK-Cu modulates inflammatory cytokines, helping to downregulate NF-B signaling, offering significant utility in systemic inflammation research
\n\n\n\n Studies in rodent models of cardiac arrhythmia, heart failure, and myocardial infarction found that BPC-157 appeared to exert cardioprotective effects, reducing the extent of tissue damage following experimentally induced cardiac events and supporting functional research applications